Anlotinib Combined with Cranial Radiotherapy for Non-Small Cell Lung Cancer Patients with Brain Metastasis: A Retrospectively, Control Study

INTRODUCTION: Cranial radiotherapy (CRT) is the main treatment for non-small cell lung cancer (NSCLC) with brain metastasis (BM) and non-EGFR/ALK/ROS1-TKIs indication, and anlotinib can improve overall prognosis. However, the clinical effects of CRT combined with anlotinib for the treatment of NSCLC...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Zelai, Liu, Jia, Ma, Yuwei, Jiang, Hao, Cui, Zhen, Wang, Guowen, Wu, Yufeng, Liu, Jiuzhou, Cai, Xixi, Qian, Jing, Huang, Jingwen, Zhang, Huijun, Li, Hongwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8349551/
https://www.ncbi.nlm.nih.gov/pubmed/34377028
http://dx.doi.org/10.2147/CMAR.S319650

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8349551/
https://www.ncbi.nlm.nih.gov/pubmed/34377028
http://dx.doi.org/10.2147/CMAR.S319650

Ejemplares similares